SUD Chronic Care Management Automation FAQ | Tile Healthcare
Learn how AI automation optimizes Chronic Care Management for Substance Use Disorders while ensuring 42 CFR Part 2 compliance and MAT retention.
Automating Chronic Care Management (CCM) and Advanced Primary Care Management (APCM) for Substance Use Disorders requires a balance of rigorous 42 CFR Part 2 compliance and high-touch patient engagement. Our AI-driven call solutions help SUD practices manage MAT adherence, monitor relapse risks, and capture new BHI revenue streams like G0568-G0570 without increasing administrative burden.
Regulatory & Compliance
4 questionsOur AI systems use granular data partitioning and specific consent triggers to ensure that SUD records are only shared with authorized parties. Every interaction is logged with a timestamped audit trail, maintaining the strict confidentiality required for addiction treatment records while allowing for seamless care coordination.
Yes, automated workflows can capture and document the specific verbal or digital consent required under 42 CFR Part 2. The AI can be programmed to verify identity and confirm consent before proceeding with any discussion regarding medication-assisted treatment or behavioral health history.
Absolutely. In addition to meeting HIPAA standards, our platform is designed for the higher privacy thresholds of substance use treatment. All data is encrypted at rest and in transit, and we provide comprehensive Business Associate Agreements that reflect current SAMHSA and HHS guidelines.
The AI schedules follow-up appointments and sends automated reminders specifically for telehealth sessions. It can also conduct pre-visit screenings to ensure patients have the necessary technology and environment for a private, compliant remote MAT consultation.
Ready to transform your substance use disorders practice?
See how Tile Healthcare's AI call center can handle scheduling, triage, and patient communication for your practice.
Schedule a Demo